{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:16:25Z","timestamp":1787728585979,"version":"build-2784847793"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"DOI":"10.1186\/s12894-025-01844-1","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T09:05:01Z","timestamp":1751533501000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The relationship between the triglyceride glucose-waist height ratio and benign prostatic hyperplasia in middle-aged and elderly adults: a nationwide cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Bing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"issue":"2","key":"1844_CR1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.pop.2019.02.003","volume":"46","author":"RC Langan","year":"2019","unstructured":"Langan RC. Benign Prostatic Hyperplasia. Prim Care. 2019;46(2):223\u201332.","journal-title":"Prim Care"},{"issue":"8","key":"1844_CR2","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.medcli.2024.04.014","volume":"163","author":"S Infante Hern\u00e1ndez","year":"2024","unstructured":"Infante Hern\u00e1ndez S, G\u00f3mez Rivas J, Moreno Sierra J. Benign prostatic hyperplasia. Med Clin (Barc). 2024;163(8):407\u201314.","journal-title":"Med Clin (Barc)"},{"issue":"4","key":"1844_CR3","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/bju.15229","volume":"127","author":"CM Devlin","year":"2021","unstructured":"Devlin CM, Simms MS, Maitland NJ. Benign prostatic hyperplasia - what do we know? BJU Int. 2021;127(4):389\u201399.","journal-title":"BJU Int"},{"issue":"6","key":"1844_CR4","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1097\/JU.0000000000003714","volume":"210","author":"SA Kaplan","year":"2023","unstructured":"Kaplan SA. Benign Prostatic Hyperplasia. J Urol. 2023;210(6):908\u201310.","journal-title":"J Urol"},{"issue":"3","key":"1844_CR5","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ajur.2017.06.004","volume":"4","author":"KB Lim","year":"2017","unstructured":"Lim KB. Epidemiology of clinical benign prostatic hyperplasia. Asian J Urol. 2017;4(3):148\u201351.","journal-title":"Asian J Urol"},{"issue":"4","key":"1844_CR6","doi-asserted-by":"publisher","first-page":"155798832110367","DOI":"10.1177\/15579883211036786","volume":"15","author":"XF Xu","year":"2021","unstructured":"Xu XF, Liu GX, Guo YS, Zhu HY, He DL, Qiao XM, Li XH. Global, regional, and national incidence and year lived with disability for benign prostatic hyperplasia from 1990 to 2019. Am J Mens Health. 2021;15(4):15579883211036786.","journal-title":"Am J Mens Health"},{"issue":"5","key":"1844_CR7","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/S0090-4295(94)80207-6","volume":"44","author":"FL Gu","year":"1994","unstructured":"Gu FL, Xia TL, Kong XT. Preliminary study of the frequency of benign prostatic hyperplasia and prostatic cancer in China. Urology. 1994;44(5):688\u201391.","journal-title":"Urology"},{"issue":"4","key":"1844_CR8","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s11934-996-0006-0","volume":"7","author":"DA Taub","year":"2006","unstructured":"Taub DA, Wei JT. The economics of benign prostatic hyperplasia and lower urinary tract symptoms in the United States. Curr Urol Rep. 2006;7(4):272\u201381.","journal-title":"Curr Urol Rep"},{"issue":"3","key":"1844_CR9","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.eururo.2006.05.001","volume":"50","author":"A Hutchison","year":"2006","unstructured":"Hutchison A, Farmer R, Chapple C, Berges R, Pientka L, Teillac P, Borkowski A, Dobronski P. Characteristics of patients presenting with LUTS\/BPH in six European countries. Eur Urol. 2006;50(3):555\u201361 discussion 562.","journal-title":"Eur Urol"},{"issue":"3\u20134","key":"1844_CR10","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/jocn.12636","volume":"24","author":"JD Pinto","year":"2015","unstructured":"Pinto JD, He HG, Chan SW, Toh PC, Esuvaranathan K, Wang W. Health-related quality of life and psychological well-being in patients with benign prostatic hyperplasia. J Clin Nurs. 2015;24(3\u20134):511\u201322.","journal-title":"J Clin Nurs"},{"issue":"3","key":"1844_CR11","doi-asserted-by":"publisher","first-page":"e0212963","DOI":"10.1371\/journal.pone.0212963","volume":"14","author":"J Lim","year":"2019","unstructured":"Lim J, Kim J, Koo SH, Kwon GC. Comparison of triglyceride glucose index, and related parameters to predict insulin resistance in Korean adults: An analysis of the 2007\u20132010 Korean National Health and Nutrition Examination Survey. PLoS One. 2019;14(3):e0212963.","journal-title":"PLoS One"},{"issue":"1","key":"1844_CR12","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12933-024-02336-6","volume":"23","author":"Q Ren","year":"2024","unstructured":"Ren Q, Huang Y, Liu Q, Chu T, Li G, Wu Z. Association between triglyceride glucose-waist height ratio index and cardiovascular disease in middle-aged and older Chinese individuals: a nationwide cohort study. Cardiovasc Diabetol. 2024;23(1):247.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"1844_CR13","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12944-024-02155-4","volume":"23","author":"Y Zhuang","year":"2024","unstructured":"Zhuang Y, Wang Y, Sun P, Ke J, Chen F. Association between triglyceride glucose-waist to height ratio and coronary heart disease: a population-based study. Lipids Health Dis. 2024;23(1):162.","journal-title":"Lipids Health Dis"},{"issue":"10","key":"1844_CR14","first-page":"1498","volume":"48","author":"J Zhou","year":"2024","unstructured":"Zhou J, Huang H, Huang H, Peng J, Chen W, Chen F, Tang Y, Li Q, Xiong Y, Zhou L. Association of triglyceride-glucose index and its combination with adiposity-related indices with the incidence of myocardial infarction: a cohort study from the UK Biobank. Int J Obes (Lond). 2024;48(10):1498\u2013505.","journal-title":"Int J Obes (Lond)"},{"issue":"4","key":"1844_CR15","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s41440-023-01502-9","volume":"47","author":"H Miao","year":"2024","unstructured":"Miao H, Zhou Z, Yang S, Zhang Y. The association of triglyceride-glucose index and related parameters with hypertension and cardiovascular risk: a cross-sectional study. Hypertens Res. 2024;47(4):877\u201386.","journal-title":"Hypertens Res"},{"issue":"1","key":"1844_CR16","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1016\/j.jacl.2023.11.006","volume":"18","author":"HM Park","year":"2024","unstructured":"Park HM, Han T, Heo SJ, Kwon YJ. Effectiveness of the triglyceride-glucose index and triglyceride-glucose-related indices in predicting cardiovascular disease in middle-aged and older adults: a prospective cohort study. J Clin Lipidol. 2024;18(1):e70\u20139.","journal-title":"J Clin Lipidol"},{"issue":"1","key":"1844_CR17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12872-023-03232-9","volume":"23","author":"Y Li","year":"2023","unstructured":"Li Y, Gui J, Zhang X, Wang Y, Mei Y, Yang X, Liu H, Guo LL, Li J, Lei Y, et al. Predicting hypertension by obesity- and lipid-related indices in mid-aged and elderly Chinese: a nationwide cohort study from the China Health and Retirement Longitudinal Study. BMC Cardiovasc Disord. 2023;23(1):201.","journal-title":"BMC Cardiovasc Disord"},{"key":"1844_CR18","doi-asserted-by":"publisher","first-page":"1201132","DOI":"10.3389\/fendo.2023.1201132","volume":"14","author":"Y Li","year":"2023","unstructured":"Li Y, Gui J, Liu H, Guo LL, Li J, Lei Y, Li X, Sun L, Yang L, Yuan T, et al. Predicting metabolic syndrome by obesity- and lipid-related indices in mid-aged and elderly Chinese: a population-based cross-sectional study. Front Endocrinol (Lausanne). 2023;14:1201132.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"1844_CR19","doi-asserted-by":"publisher","first-page":"986","DOI":"10.47391\/JPMA.22-63","volume":"72","author":"VK Ramdas Nayak","year":"2022","unstructured":"Ramdas Nayak VK, Satheesh P, Shenoy MT, Kalra S. Triglyceride Glucose (TyG) index: a surrogate biomarker of insulin resistance. J Pak Med Assoc. 2022;72(5):986\u20138.","journal-title":"J Pak Med Assoc"},{"issue":"1","key":"1844_CR20","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s41043-025-00878-3","volume":"44","author":"WZ Jiang","year":"2025","unstructured":"Jiang WZ, Fan ZL, Xu ML, Qian EH, Lu KD. Association between insulin resistance and multiple chronic diseases: a cross-sectional study from CHARLS. J Health Popul Nutr. 2025;44(1):148.","journal-title":"J Health Popul Nutr"},{"key":"1844_CR21","first-page":"249","volume":"370","author":"CP Wu","year":"1991","unstructured":"Wu CP, Gu FL. The prostate in eunuchs. Prog Clin Biol Res. 1991;370:249\u201355.","journal-title":"Prog Clin Biol Res"},{"issue":"1","key":"1844_CR22","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1186\/s12967-022-03722-y","volume":"20","author":"YB Wang","year":"2022","unstructured":"Wang YB, Yang L, Deng YQ, Yan SY, Luo LS, Chen P, Zeng XT. Causal relationship between obesity, lifestyle factors and risk of benign prostatic hyperplasia: a univariable and multivariable Mendelian randomization study. J Transl Med. 2022;20(1):495.","journal-title":"J Transl Med"},{"key":"1844_CR23","doi-asserted-by":"publisher","first-page":"1290639","DOI":"10.3389\/fendo.2023.1290639","volume":"14","author":"X Rao","year":"2023","unstructured":"Rao X, Xu Z, Zhang J, Zhou J, Huang J, Toh Z, Zheng R, Zhou Z. The causal relationship between sarcopenic obesity factors and benign prostate hyperplasia. Front Endocrinol (Lausanne). 2023;14:1290639.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1844_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41514-025-00231-2","volume":"11","author":"AV Schally","year":"2025","unstructured":"Schally AV, Theodoropoulos G, Sha W, Vidaurre I, Wangpaichitr M. A 50-year journey in the development of treatment for benign prostatic hyperplasia. NPJ Aging. 2025;11(1):41.","journal-title":"NPJ Aging"},{"issue":"1","key":"1844_CR25","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/s42003-024-07071-y","volume":"7","author":"PO Cooper","year":"2024","unstructured":"Cooper PO, Yang J, Wang HH, Broman MM, Jayasundara SM, Sahoo SS, Yan B, Awdalkreem GD, Cresswell GM, Wang L, et al. Inflammation impacts androgen receptor signaling in basal prostate stem cells through interleukin 1 receptor antagonist. Commun Biol. 2024;7(1):1390.","journal-title":"Commun Biol"},{"key":"1844_CR26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jare.2023.04.006","volume":"57","author":"BR Jin","year":"2024","unstructured":"Jin BR, Kim HJ, Na JH, Lee WK, An HJ. Targeting benign prostate hyperplasia treatments: AR\/TGF-\u03b2\/NOX4 inhibition by apocynin suppresses inflammation and proliferation. J Adv Res. 2024;57:135\u201347.","journal-title":"J Adv Res"},{"key":"1844_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/978-3-319-95693-0_3","volume":"1095","author":"AK Tewari","year":"2018","unstructured":"Tewari AK, Stockert JA, Yadav SS, Yadav KK, Khan I. Inflammation and prostate cancer. Adv Exp Med Biol. 2018;1095:41\u201365.","journal-title":"Adv Exp Med Biol"},{"issue":"12","key":"1844_CR28","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1172\/JCI21625","volume":"114","author":"S Furukawa","year":"2004","unstructured":"Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004;114(12):1752\u201361.","journal-title":"J Clin Invest"},{"issue":"3","key":"1844_CR29","doi-asserted-by":"publisher","first-page":"R113","DOI":"10.1530\/JOE-14-0283","volume":"222","author":"M Mraz","year":"2014","unstructured":"Mraz M, Haluzik M. The role of adipose tissue immune cells in obesity and low-grade inflammation. J Endocrinol. 2014;222(3):R113-127.","journal-title":"J Endocrinol"},{"key":"1844_CR30","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/329456","volume":"2014","author":"G Corona","year":"2014","unstructured":"Corona G, Vignozzi L, Rastrelli G, Lotti F, Cipriani S, Maggi M. Benign prostatic hyperplasia: a new metabolic disease of the aging male and its correlation with sexual dysfunctions. Int J Endocrinol. 2014;2014: 329456.","journal-title":"Int J Endocrinol"},{"issue":"3","key":"1844_CR31","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/luts.12420","volume":"14","author":"W Chen","year":"2022","unstructured":"Chen W, Man S, Wang B, Kadeerhan G, Huang X. Metabolically healthy obesity is associated with increased risk of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a cohort study of Chinese elderly males. Low Urin Tract Symptoms. 2022;14(3):170\u20137.","journal-title":"Low Urin Tract Symptoms"},{"issue":"2","key":"1844_CR32","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.mce.2011.12.017","volume":"351","author":"G Williams","year":"2012","unstructured":"Williams G. Aromatase up-regulation, insulin and raised intracellular oestrogens in men, induce adiposity, metabolic syndrome and prostate disease, via aberrant ER-\u03b1 and GPER signalling. Mol Cell Endocrinol. 2012;351(2):269\u201378.","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"1844_CR33","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.eururo.2014.10.016","volume":"67","author":"A Tubaro","year":"2015","unstructured":"Tubaro A, De Nunzio C, Puccini F, Presicce F. The evolving picture of lower urinary tract symptom management. Eur Urol. 2015;67(2):271\u20132.","journal-title":"Eur Urol"},{"issue":"4","key":"1844_CR34","doi-asserted-by":"publisher","first-page":"e0301011","DOI":"10.1371\/journal.pone.0301011","volume":"19","author":"G Fan","year":"2024","unstructured":"Fan G, Guan X, Guan B, Zhu H, Pei Y, Jiang C, Xiao Y, Li Z, Cao F. Untargeted metabolomics reveals that declined PE and PC in obesity may be associated with prostate hyperplasia. PLoS One. 2024;19(4):e0301011.","journal-title":"PLoS One"},{"issue":"1","key":"1844_CR35","doi-asserted-by":"publisher","first-page":"8743","DOI":"10.1038\/s41598-024-81629-y","volume":"15","author":"B Li","year":"2025","unstructured":"Li B, Zhang Z, Sun C, Sun Y, Li J, Liu X. Association between TyG-BMI and BPH in a national prospective cohort study. Sci Rep. 2025;15(1):8743.","journal-title":"Sci Rep"},{"key":"1844_CR36","unstructured":"Feingold KR: Introduction to Lipids and Lipoproteins. In: Endotext. edn. Edited by Feingold KR, Ahmed SF, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K et al. South Dartmouth (MA): MDText.com, Inc. Copyright \u00a9 2000-2025, MDText.com, Inc.; 2000."},{"issue":"6","key":"1844_CR37","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1172\/JCI28735","volume":"116","author":"PE Cryer","year":"2006","unstructured":"Cryer PE. Mechanisms of sympathoadrenal failure and hypoglycemia in diabetes. J Clin Invest. 2006;116(6):1470\u20133.","journal-title":"J Clin Invest"},{"issue":"4","key":"1844_CR38","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/met.2008.0034","volume":"6","author":"LE Simental-Mend\u00eda","year":"2008","unstructured":"Simental-Mend\u00eda LE, Rodr\u00edguez-Mor\u00e1n M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299\u2013304.","journal-title":"Metab Syndr Relat Disord"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01844-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-025-01844-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01844-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T09:05:04Z","timestamp":1751533504000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-025-01844-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1844"],"URL":"https:\/\/doi.org\/10.1186\/s12894-025-01844-1","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]},"assertion":[{"value":"12 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Biomedical Ethics Review Committee of Peking University (IRB00001052-11015). All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for<!--Emphasis Type='Bold' removed-->publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing<!--Emphasis Type='Bold' removed-->interests"}}],"article-number":"153"}}